Drugs / Sodium Picosulfate/Magnesium Oxide/Citric Acid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06580366 Comparator | Aug → Dec 2024 overdue | — | Hitit University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Picosulfate/Magnesium Oxide/Citric Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06580366 ↗ |
| Known as | PM/Ca | “This study aimed to compare the effectiveness and tolerability of sennoside A + B versus sodium picosulfate/magnesium oxide/citric acid (PM/Ca) using the Boston Bowel...” PMID 42135569 ↗ May 2026 |